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Extensive axonal pruning and neuronal cell death are
critical events for the development of the nervous
system. Like neuronal cell death, axonal elimination
occurs in discrete steps; however, the regulators of
these processes remain mostly elusive. Here, we
identify the kinesin superfamily protein 2A (KIF2A)
as a key executor of microtubule disassembly and
axonal breakdown during axonal pruning. Knock-
down of Kif2a, but not other microtubule depoly-
merization or severing proteins, protects axonal
microtubules from disassembly upon trophic depri-
vation.We further confirmed and extended this result
to demonstrate that the entire degeneration process
is delayed in neurons from the Kif2a knockout mice.
Finally, we show that the Kif2a-null mice exhibit
normal sensory axon patterning early during devel-
opment, but abnormal target hyperinnervation later
on, as they compete for limited skin-derived trophic
support. Overall, these findings reveal a central
regulatory mechanism of axonal pruning during
development.
INTRODUCTION
The nervous system is shaped during development by progres-
sive and regressive events. Axonal pruning, a strategy used by
the nervous system to remove exuberant or misguided connec-
tions, often occurs via local axonal degeneration (Coleman,
2005; Low and Cheng, 2006; Luo and O’Leary, 2005). The
degeneration process is characterized by a series of discrete
steps. Disassembly of microtubules (MTs) is the earliest cellular
event, which is followed by degradation of other cytoskeletal
elements, such as neurofilaments (NFs) and fragmentation of
the axon (Watts et al., 2003; Zhai et al., 2003). This series of steps
is also exhibited in injured axons following nerve transection
(Zhai et al., 2003). To date, the mechanisms and molecules
executing MT breakdown are largely unknown. Moreover, thecausal relationship betweenMT integrity and breakdown of other
cytoskeletal components during axonal degeneration is unclear
(Saxena and Caroni, 2007).
Here, we show that the MT-stabilizing agent paclitaxel
protects against MT disassembly in different paradigms of
axonal degeneration, trophic (NGF) deprivation, or axotomy.
We further demonstrate that this protection can be largely
mimicked by ablation of a single MT-depolymerization protein
of the kinesin-13 family, kinesin superfamily protein 2A (KIF2A).
Interestingly, degradation of Tau (tubulin-associated unit) pre-
cedes MT breakdown by KIF2A. However, this degradation is
not sufficient to induce MT disassembly by itself. Last, we
demonstrate that the initial growth and arrangement of sensory
axons, which are NGF independent, are perfectly normal in
Kif2a-null mice. However, these mice exhibit severe skin hyper-
innervation by sensory axons, a process that is restricted by
competition for limited trophic support. Overall, these findings
uncover a key regulatory mechanism of axonal pruning during
development.
RESULTS
MT Depolymerization Is Inhibited by the MT-Stabilizing
Agent Paclitaxel
MT-destabilization drugs, such as vincristine or colchicine,
induce axonal degeneration (Saxena and Caroni, 2007). How-
ever, whetherMT-stabilization drugs can preventMT breakdown
during axonal degeneration is not known. Therefore, we tested
whether paclitaxel, a strongMT polymerization agent, can inhibit
MT depolymerization in two in vitro models of axonal degenera-
tion; trophic (NGF) deprivation, in which axons degenerate due
to lack of trophic support, representing a developmental elimina-
tion process, and axotomy in which axons are cut from their cell
bodies. Dorsal root ganglia (DRGs) were dissected from mouse
embryos at embryonic day 13.5 (E13.5), and, after 48 hr in cul-
ture, axonal degeneration was induced and the MTs underwent
depolymerization (Figures 1A–1C and 1G). Application of pacli-
taxel caused inhibition of the MT depolymerization process in
both models, with the MTs appearing intact (Figures 1D–1G).
To further characterize the cytoskeletal changes during degener-
ation, we conducted a biochemical analysis of NGF-deprivedCell Reports 3, 971–977, April 25, 2013 ª2013 The Authors 971
Figure 1. Paclitaxel Protects MT from Degradation upon NGF Deprivation, but NFs Are Only Minimally Protected
(A–G) DRG explants were cultured for 48 hr in NGF-containingmedium. For the following 24 hr, they were supplied with NGF (A and D), deprived of NGF (B and E),
or axotomized for 8 hr (C and F). The explants were then immunostained for tubulin bIII. Upon NGF deprivation or axotomy, the MTs undergo breakdown, as can
be seen by the punctuated form of the MTs (B, C, and G). The addition of 10 mM paclitaxel protected the MTs, as no degradation was detected 24 hr after NGF
deprivation (E–G). MT depolymerization average index value ± SD was calculated for each condition (G), Mann-Whitney test, ***p < 0.001.
(H) Biochemical analysis of the axonal cytoskeleton. DRG explants were cultured for 48 hr in NGF-containing medium. For the next 20 hr, these explants were
either supplied with (+) or deprived of () NGF.MT polymerization level was evaluated using immunoblot analysis for a-tubulin and its PTMs antibodies. MTs were
both degraded, as detected by total a-tubulin, and depolymerized as revealed by the strong reduction in acetylation, detyrosination, and polyglutamylation state,
upon NGF deprivation. In the presence of 10 mM paclitaxel, MTs remained polymerized and were not degraded. NF degradation observed after NGF deprivation
was only slightly attenuated in the presence of paclitaxel. Scale bar, 100 mM.
See also Figure S1.axons (Figure 1H). In agreement with the cellular analysis, pacli-
taxel inhibited MT degradation after NGF withdrawal, as in its
presence there was no reduction in a-tubulin (Figure 1H). Next,
we examined the changes in tubulin posttranslation modifica-
tions (PTMs), which mark subpopulations of MTs during the
degeneration process. Several modifications, including acetyla-
tion, detyrosination, and glutamylation, are enriched in stable
MTs (Verhey and Gaertig, 2007). Indeed, following NGF with-
drawal, we detected a strong decrease in these modifications,
indicating MT destabilization. However, in the presence of pacli-
taxel, the MTs remained polymerized as indicated by all the
tubulin PTMs examined (Figure 1H). In contrast to its powerful
stabilizing effect on MTs, paclitaxel showed only minor protec-
tion of NFs, which are degraded during the axonal degeneration
process (Figure 1H). This implies that other pathways operate in
parallel to MT depolymerization during axonal elimination.
Similar results were obtained using the axotomy model (Fig-
ure S1). Overall, these results suggest that elevation of MT poly-
merization can protect them from disassembly during axonal
degeneration.972 Cell Reports 3, 971–977, April 25, 2013 ª2013 The AuthorsDegradation of the MT-Stabilizing Protein, Tau, Is
Insufficient for Inducing Axonal MT Depolymerization
The experiments with paclitaxel prompted us to hypothesize that
specific MT-stabilizing proteins might be degraded during
axonal degeneration. Tau (also known as MAPT) belongs to a
widespread family of MAPs. It is an abundant protein in the cen-
tral and peripheral nervous system, where it is expressed pre-
dominantly in neurons and enriched in axons and, like paclitaxel,
promotes tubulin assembly into MTs (Binder et al., 1985). Impor-
tantly, Tau binds to a site on b-tubulin that overlaps the paclitaxel
site (Kar et al., 2003). In addition, hyperphosphorylation of Tau
and its subsequent degradation prevent it from binding to MTs,
leading to a decrease in MT stability (Lindwall and Cole, 1984).
Tau is a known substrate of caspase-6, which is activated
upon NGF deprivation within axons (Graham et al., 2011).
In light of the above, we monitored the fate of axonal Tau after
NGF deprivation or axotomy using an insert culture system that
enables effective purification of axonal material (Schoenmann
et al., 2010). Degradation of Tau was detected 14 hr after trophic
withdrawal, when the axonal MTs are still intact (Figure 2A). The
Figure 2. Tau Degradation Is Not Sufficient for Promoting MT Breakdown
(A and B) DRG explants were cultured for 48 hr in NGF-containing medium. These explants were then deprived of NGF for 14 hr (A) or axotomized for 4 hr (B).
Axonal Tau was detected by western blot using two antibodies, Tau5 (total Tau) and PHF (phosphorylated Tau). A significant reduction of total Tau was detected
using Tau5 antibody 14 hr after NGFwithdrawal, while the phosphorylated formwas only slightly reduced (A). Both antibodies detected clear reduction of Tau 4 hr
after axotomy (B).
(C–G) Tau expression was reduced using siRNA treatment as detected by Tau5 and PHF (C), yet this reduction did not induce MT depolymerization, as evaluated
by both the immunostaining for bIII tubulin (D and E) and immunoblotting for a-tubulin, acetylation, detyrosination, and polyglutamylation (G). MT stability average
index value ± SD was calculated for each siRNA treatment (F), Mann-Whitney test. NS, nonsignificant.
Scale bar, 100 mM. See also Figures S2 and S3.hyperphosphorylated form of Tau was only slightly reduced in
this time frame (Figure 2A). This might indicate that Tau is hyper-
phosphorylated during trophic deprivation. Tau was completely
degraded by 20 hr (Figure S2). In addition, at 4 hr postaxotomy
the level of Tau was reduced, and by 6 hr it was eliminated (Fig-
ures 2B and S2). However, treatment of the sensory neuronal
cultures with small interfering RNA (siRNA) against Tau did not
induce axonal MT depolymerization (Figures 2D–2G), even
though Tau was markedly reduced (Figure 2C). These results
indicate that the degradation of Tau during axonal degeneration
is not in itself sufficient to induce MT depolymerization.
Knockdown of Kif2a, but Not Other MT-Severing
Proteins, Inhibits MT Depolymerization
The inability of Tau knockdown to induce axonal MT depolymer-
ization may be due to lack of strong MT depolymerization activ-
ity. Therefore, we examined the role of MT-destabilizing proteins
in axonal MTs depolymerization, using siRNA knockdown in
combination with the NGF-deprivation model. We screened
several candidates, including the four Stathmin family members
(Stmn1–4), Katanin, Spastin, and Kif2a (Conde and Ca´ceres,
2009). Strikingly, only the knockdown of Kif2a strongly inhibited
MT depolymerization, revealing MT preservation 24 hr after NGF
withdrawal (Figure S3).Genetic Ablation of Kif2a Delays MT Disassembly and
Axonal Degeneration
To further establish the role of Kif2a in initiating axonal fragmen-
tation, we performed a temporal analysis of axonal degeneration
after NGF deprivation using neurons from the Kif2a knockout
(KO) mice (Homma et al., 2003). Clear inhibition in MT depoly-
merization and its subsequent degradation can be detected at
all time points 18–27 hr after NGF deprivation (Figures 3A–3K).
However, by 30 hr the MTs from the Kif2a KO neurons were
completely depolymerized as well, representing a delay of up
to 9 hr. These cellular results are also supported by our biochem-
ical analysis as ablation ofKif2a preservedMT integrity fromboth
depolymerization and degradation, while NF degradation was
only slightly attenuated in Kif2a KOmice (Figure 3L). Importantly,
the protection is not due to inhibition of caspase-3, as it is fully
active in the Kif2a KO axons (Figure S4). Tau degradation was
also attenuated, in both paclitaxel-treated and Kif2a KO neurons
(Figures 3M and 3N). Therefore, under conditions in which the
MTs are preserved, Tau might still be bound to the polymerized
MTs, this shade Tau from the degradation machinery.
In the Kif2a KO neurons, a clear protection of the MTs was
observed 8 hr after axotomy (Figures 3O–3Q). Yet by 12 hr the
MTs were depolymerized. In addition, MT degradation was
attenuated, as indicated by the preservation of a-tubulin, whileCell Reports 3, 971–977, April 25, 2013 ª2013 The Authors 973
Figure 3. Genetic Ablation of Kif2a Delays MT Depolymerization upon NGF Deprivation
(A–K) DRG explants of either Kif2a KO embryos (F–J) or WT littermate (A–E) were cultured for 48 hr in NGF-containing medium. These explants were either
supplied with (A and F) or deprived of (B–E and G–J) NGF for an additional 18 (B and G), 21 (C and H), 24 (D and I), and 27 hr (E and J) and then immunostained for
tubulin bIII. Deprived of NGF, the axonal MTs of the WT neurons were depolymerized and degraded, as can be seen by the punctuated form of the MTs (B–E). In
contrast, the axonal MTs breakdown of the Kif2a KO neurons was inhibited after NGF deprivation (G–J). MT depolymerization average index value ± SD was
calculated for each condition and genotype (K), Mann-Whitney test, ***p < 0.001.
(L) Genetic ablation of Kif2a protects MT but hardly protects NFs from degradation upon NGF deprivation. DRG explants were cultured for 48 hr in NGF-con-
taining medium. Then they were deprived of NGF for the next 20 hr. MT polymerization level was evaluated using immunoblot analysis for a-tubulin and its PTM
antibodies. In WT axons upon NGF deprivation, MTs were both degraded, as detected by a-tubulin and depolymerized, as detected by the reduction in acet-
ylation, detyrosination, and polyglutamylation. In theKif2a KO axons, MTsweremore polymerized and less degraded. NF degradation upon NGF deprivation was
only slightly attenuated in the Kif2a KO neurons, compared to the WT controls.
(M andN) Tau degradation following NGF deprivation is attenuated by eitherKif2a ablation or paclitaxel. Tau levels were evaluated bywestern blot using Tau5 and
PHF antibodies. In the presence of 10 mM paclitaxel (N), or the genetic ablation of Kif2a (M), the degradation of Tau was attenuated.
(O–Q) Kif2a ablation protects MTs from degradation after axotomy. DRG explants were cultured for 48 hr in NGF-containing medium. These explants axons were
transected and immunostained for tubulin bIII at 8 hr after the transaction (O and P). Upon transection, the MTs undergo breakdown, as can be seen by the
punctuated form of the MTs (O). While in the Kif2a KO, MTs were protected and only a small fraction was degraded 8 hr after transaction (P). Quantification of a
MTs depolymerization average index value ± SD was calculated for each condition and genotype (P), Mann-Whitney test, ***p < 0.001.
(R–X) Kif2a ablation delays axonal degeneration. DRG explants from WT (R–T) and Kif2a KO (U–W) embryos were cultured, treated as described above, and
imaged by phase microscopy. Axonal degeneration average index value ± SEMwas calculated from each condition and genotype (X), Mann-Whitney test, ***p <
0.001. Scale bar, 100 mM.
See also Figures S4 and S5.its PTM levels were preserved only to a small extent (Figure S5).
Finally, the overall axonal structure was preserved as observed
by phase microscopy in the Kif2a KO axons 24 hr after trophic
withdrawal and, to a small degree, 8 hr after axotomy (Figures
3R–3X). In summary, these results demonstrate that, upon
trophic withdrawal and (to a lesser extent) after axotomy,
KIF2A plays a key role in MT depolymerization and axonal
degeneration.974 Cell Reports 3, 971–977, April 25, 2013 ª2013 The AuthorsKO of Kif2a Causes Skin Hyperinnervation
Gain- and loss-of-function studies have established skin-derived
NGF as a key regulator of innervation by sensory axons during
development (Albers et al., 1994; Patel et al., 2000; Wickrama-
singhe et al., 2008). Therefore, we postulated that the resistance
of Kif2a KO sensory axons to NGF deprivation would lead to
hyperinnervation of the skin by these axons. To test this hypoth-
esis, we stained sections of E15.5 embryos, Kif2a KO, and
Figure 4. Kif2a KO Mice Exhibit Developmental Skin Hyperinnervation by Sensory Axons
(A–G) Paraffin sections of E15.5 embryos. Shown here are peripheral axons adjacent to the skin labeled with antitubulin bIII antibody (A and B) and confocal
analysis of the same sections (C and E) of (A) and (D and F) of (B). Hyperinnervation of the sensory axons was detected inKif2aKO (B, D, and F) when compared to
their WT littermate embryos (A, C, and E). Innervation density index value ± SD was calculated from 180 sections of four embryos from each genotype (G), Mann-
Whitney test, ***p < 0.001.
(H–L) The peripheral nervous system pattern in the Kif2a KO mice is normal early during development. As can be detected in whole-mount anti-NF analysis of
E12.5WT (H) andKif2aKO (I) and in the section of nerves, labeled with tubulin bIII antibody, exiting the DRGat E12.5 (J and K). Nerve density index value ±SDwas
calculated from 360 sections of four embryos from each genotype (L), N.S., nonsignificant.
(M–O) The number of sensory neurons in the DRGs does not differ in the Kif2a KO mice, as detected by islet1 antibody, in E15.5 WT (M) and Kif2a KO (N). Total
Islet1-positive neurons ± SD was calculated from 110 sections of three embryos of each genotype (O). N.S., nonsignificant.
Scale bars, 50 mM (A–D, J, K, M, and N) and 20 mM (E and F).wild-type (WT) littermates and examined the innervation of the
skin in the ventral body surface. Significant enhancement was
detected in the amount of axons innervating the skin in the
Kif2a KO embryos (Figures 4A–4G). The pattern of cutaneous
sensory axons early during development at E12.5 is NGF
independent (Davies et al., 1987; Lumsden and Davies, 1983;
Wickramasinghe et al., 2008). Indeed, we did not detect any
abnormalities in the growth, branching, or nerve density of these
axons in the Kif2a KO embryos at E12.5 (Figures 4H–4L). More-
over, the number of sensory neurons in the DRG at E15.5 (when
the skin hyperinnervation is observed) is identical between WT
and Kif2a KO (Figures 4M–4O). Thus, Kif2a KO enables sensory
axons to hyperinnervate the skin between E12.5 and E15.5 in the
presence of limited trophic support.
DISCUSSION
Microtubule breakdown is a hallmark of axonal degeneration,
both during development and after injury (Watts et al., 2003;
Zhai et al., 2003). However, the mechanism of MT breakdown
during the degeneration process has yet to be elucidated.
Here, we show that MT depolymerization is an active process
that is regulated by a specific disassembly protein, KIF2A.
Whether other severing proteins control MT disassembly during
axonal pruning remains an open question. Studies in the fly did
not reveal, so far, a role for Stathmin, Katanin, or Spastin in neu-rite pruning and degeneration (Graf et al., 2011; Lee et al., 2009;
Stone et al., 2012; Tao and Rolls, 2011). Interestingly, it was
recently suggested that stathmin2/SCG10 delays axonal degen-
eration upon axotomy (Shin et al., 2012).
How is KIF2A regulated during axonal degeneration? We did
not observe any elevation in KIF2A protein levels, suggesting
that it is not regulated at the transcriptional or translational level
upon trophic withdrawal (Figure S3). In principle, KIF2A might be
constitutively active, and simple elimination of MAPs would then
enable its action. However, our results argue against this model,
as in such case axonal degeneration should have been observed
by knockdown of Tau or Crmp2. Instead, we propose that
signaling events that initiate the degeneration process stimulate
the activity of KIF2A. In agreement, several reports have shown
that KIF2A activity is controlled by phosphorylation (Jang et al.,
2009; Mennella et al., 2009; Noda et al., 2012). Therefore,
kinases that regulate the axonal self-destruction program may
activate KIF2A.
Previous studies and our work suggest that the cell employs
parallel degeneration pathways to disassemble the axonal cyto-
skeleton. The calpain inhibitor ALLN or inhibition of the IkB
kinase (IKK) specifically prevent NF degradation (Gerdts et al.,
2011; Zhai et al., 2003). In contrast, paclitaxel treatment and
Kif2a ablation were found to protect MTs. However, it seems
that some level of coregulation of these pathways does exist
as protecting the MTs very partially preserves the NFs afterCell Reports 3, 971–977, April 25, 2013 ª2013 The Authors 975
NGF withdrawal. More importantly, we observed that axonal
structure is largely preserved after trophic deprivation in Kif2a
KO neurons. This suggests that although the cell employs
several parallel pathways to eliminate cytoskeletal and regula-
tory proteins, depolymerization of MTs is a critical event that
regulates other destruction pathways. This may also explain
why depolymerization of MTs but not actin or NFs elimination
induces axonal degeneration (Walker et al., 2001; Zhai et al.,
2003).
The neurotrophic hypothesis argues that proper skin innerva-
tion by sensory axons is achieved through competition for a
limited amount of NGF (Davies, 1996; Harper and Davies,
1990). Our results suggest that axonal pruning by KIF2A is an
important part of this process. The hyperinnervation we detect
in the Kif2a KOmice is not due to interference with the apoptotic
machinery, which is not impaired in these neurons, as the
number of DRG neurons in the Kif2a KO is indistinguishable
from the number in the WT. Moreover, the NGF-independent
initial growth and pattern of sensory axons is normal early in
development, suggesting that there is no general alteration of
these axons as was previously observed in the CNS (Homma
et al., 2003). Therefore, Kif2a is a pruning factor that regulates
target innervation by sensory axons. Whether Kif2a controls
axonal pruning in the CNS or pathological degeneration of the
nervous system remains to be discovered.EXPERIMENTAL PROCEDURES
Antibodies
Antibodies and dilutions used for immunofluorescence staining: tubulin b-III
(Covance, MRB-435P, 1:1,000), cleaved caspase-3 (Cell Signaling, 9664,
1:100). Anti-mouse or anti-rabbit antibodies conjugated with either Alexa
549 or Alexa 488 fluorophores were used at 1:200 (Jackson ImmunoResearch
Laboratories). For immunoblotting, the following antibodies and dilutions were
used: tubulin bIII (1:2000), tubulin a (Millipore, 05-829, 1:1,000), tubulin
detyrosinated (Millipore, AB3201, 1:1,000), tubulin acetylated (Convance,
MMS-413R, 1:1,000), tubulin glutamylated: GT335 and PolyE (kindly provided
by Prof. C. Janke, CRBM, 1:2,000). Tau antibodies: Tau5 and PHF1 (kindly pro-
vided by Dr. E. Elliott, produced at the Lab of Prof. I. Grinzburg, Weizmann
Institute of Science, Israel, 1:1,000), NF (2H3) and Islet1 (Developmental
Studies Hybridoma Bank, 1:10 and 1:1,000, respectively), actin (MP Biomed-
icals, 691001, 1:5,000), STMN1 (Abcam, ab52906, 1:1,000), STMN2 (kindly
provided by Prof. E Coffey, Turku University, 1:1,000), and KIF2A (Abcam,
ab37005, 1:500). Immunoblots were developed using horseradish-peroxi-
dase-labeled donkey anti-rabbit or anti-mouse IgG followed by detection
with chemiluminescence.
Mouse Strains
The Kif2a KOmouse strain was previously described (Homma et al., 2003). All
of the animal experiments were done according to the protocols that were
approved by the Weizmann Institute of Science Institutional Animal Care and
Use Committee.
Explant Culture
Dorsal root ganglion (DRG) explants of E13.5 mice were aseptically removed
and cultured on poly-d-lysine (PDL)-laminin-coated plates. The explants
were grown in neurobasal (NB) medium supplemented with 2% B-27, 1%
glutamine, 1% penicillin-streptomycin, and 25 ng/ml mNGF 2.5S (Alomone
Labs; N-100) for 48 hr before treatments. For NGF deprivation, the medium
was exchanged for medium lacking NGF with addition of 0.1 mg/ml rabbit
anti-NGF neutralizing antibodies (Alomone Labs; AN-240). Other conditions
required the addition of 10 mM paclitaxel (Sigma-Aldrich; T7191).976 Cell Reports 3, 971–977, April 25, 2013 ª2013 The AuthorsDRG-Dissociated Neurons
DRGs from E13.5 mice were aseptically removed and pelleted in Hank’s
balanced salt solution (Biological Industries, Beit Haemek, Israel) for 10 min
and dissociated with 5% trypsin 37C for 2 min. The trypsin was neutralized
with 10 ml L15 medium supplemented with 5% fetal calf serum. The cells
were then centrifuged at 2,800 rpm 21C for 4 min and resuspended in NB
medium supplemented with B-27, glutamine, and 12.5 ng/ml NGF. The
dissociated cells were cultured onto 18 mm PDL-laminin-coated coverslips
in 12-well plates.
siRNA Treatment
siRNA oligonucleotide sequences were used to target the following proteins:
Stmn1, Stmn2, Stmn3, Stmn4, Katanin, Spastin, and Kif2a (Dharmacon, ON-
TARGETplus SMARTpool). For negative control, a nontarget sequence was
used (Dharmacon, ON-TARGETplus Non-Targeting Pool, D-001810). DRG-
dissociated cells were transfected with siRNA, using the protocol supplied
with DharmaFECT 4 (Dharmacon, T-2004-03). Briefly, siRNA and the transfec-
tion reagent were each diluted separately into NB medium without serum and
antibiotics for 5 min; then, the siRNA was added to the medium with the trans-
fection reagent. After an additional 20min incubation, the transfection reagent-
siRNA complex was added to the dissociated cells, and grown in NB medium
containing 25 ng/ml NGF, without serum and antibiotics. Fifteen hours later,
the transfection reagent was removed by replacing the medium with a com-
plete medium and the neurons were cultured for an additional 48 hr. NGF
deprivation was performed as described above. The final concentration of
the siRNA was 0.1 mM. The level of the target protein, reduced by its specific
siRNA treatment, was evaluated by western blot analysis.
Axonal Caspase Activity Assay
Axonal caspase activity assay was preformed as described in Schoenmann
et al. (2010).
Immunohistochemistry of Mouse Embryos
E15.5 or E12.5 embryoswere fixed for 24 hr in 4% formaldehyde. The following
day, the embryos were embedded in paraffin, and 4 mm transversal sections
were taken. The slides then underwent deparaffinization with xylene and
ethanol. Antigen retrieval was performed in a pressure cooker in a sodium
citrate buffer at 125C. The slides were stained with tubulin b-III antibody for
axon visualization and with anti-islet1 for sensory neuron detection.
Whole-Mount Staining
E12.5 mouse embryos (Kif2a KO and WT littermates) were stained as
described (Yaron et al., 2005).
Axonal Quantification In Vitro and In Vivo
All the data were quantified using computerized algorithms; for details, please
see Extended Experimental Procedures.
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